From market consolidation to artificial intelligence, experts outlined the critical changes needed as the sector matures and highlighted key challenges that must be addressed to ensure …

Apr 1, 2024 · In 2023, several CDMOs stood out not just for their revenue but also for their significant contributions to advancing cell and gene therapies. Here's a look at the top 10 CGT …

A CDMO can help an early-stage CGT developer understand the limitations of their source cells. And the CDMO can aid in developing strategies around processing tissue, generating cell …

The global cell and gene therapy CDMO market size was estimated at USD 4.99 billion in 2023 and is expected to grow at a CAGR of 27.9% from 2024 to 2030

Mar 31, 2025 · The Global CGT CDMO Market size was valued at USD 7.05 billion in 2024 and is projected to grow significantly, reaching USD 9.2 billion in 2025 and an impressive USD 77.85 …

3 days ago · With two decades of CDMO experience, we have refined our cell and gene therapy program roadmap to accelerate production timelines and help developers navigate the …

As a leading Contract Development and Manufacturing Organization (CDMO) in CGT, we provide comprehensive solutions that accelerate the development, manufacturing and …

Dec 16, 2024 · In this article, we will explore CDMO selection for early-stage biopharma, including criteria to consider during the CDMO selection process. Criteria for CDMO selection should …

Mar 24, 2025 · The global CGT CDMO market size was USD 7.04 billion was 2024 and will touch USD 59.61 billion by 2032, exhibiting a CAGR of 30.6% during the forecast period. A CDMO in …

Jan 3, 2025 · In addition to industry giants that include Lonza, Catalent , WuXi Advanced Therapies, Minaris Regenerative Medicine, and others, there are specialty CDMOs serving the …